Open AccessWhich patients with renal cancer may benefit from sunitinib therapy?
Author(s) -
Tom Ferguson,
Martin Gore
Publication year - 2010
Publication title -
therapeutic advances in medical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 49
eISSN - 1758-8359
pISSN - 1758-8340
DOI - 10.1177/1758834009359411
Subject(s) - medicine , sunitinib , clinical trial , randomized controlled trial , renal cell carcinoma , targeted therapy , oncology , kidney cancer , immunotherapy , adjuvant , bevacizumab , cancer , bioinformatics , chemotherapy , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom